Endothelial Microparticles Derived from Primary Pulmonary Microvascular Endothelial Cells Mediate Lung Inflammation in Chronic Obstructive Pulmonary Disease by Transferring microRNA-126
Yiming Ma,Xue He,Xiangming Liu,Yingjiao Long,Yan Chen
DOI: https://doi.org/10.2147/JIR.S349818
IF: 4.5
2022-02-28
Journal of Inflammation Research
Abstract:Yiming Ma, Xue He, Xiangming Liu, Yingjiao Long, Yan Chen Department of Respiratory and Critical Care Medicine, The Second Xiangya Hospital of Central South University, Changsha, People's Republic of China Correspondence: Yan Chen; Yingjiao Long, Email ; Background: Extracellular vesicles (EVs) are considered to new types of intercellular communication media, and microRNA is one of the most common transferring components of EVs. This study aimed to explore the potential role of endothelial microparticles (EMPs) derived from primary pulmonary microvascular endothelial cells in regulating lung inflammation of chronic obstructive pulmonary disease (COPD) through transferring microRNA-126 (miR-126). Methods: EMPs generated from primary pulmonary microvascular endothelial cells were isolated by gradient centrifugation and characterized by transmission electron microscopy, flow cytometry and Western blotting. EMPs were treated to in vitro and in vivo COPD models induced by cigarette smoke extract (CSE). miR-126 mimics or inhibitors were transfected into EMPs by calcium chloride. Pathological changes of lung tissue, mRNA and protein levels of inflammation-related factors were measured to explore the effect of EMPs transferring miR-126 on CSE-induced inflammation. Results: Both in vitro and in vivo studies demonstrated that mRNA and protein levels of inflammation-related factors were significantly increased in COPD group, while EMPs could dramatically reverse these increases. In vitro, overexpression of miR-126 in EMPs decreased HMGB1 expression and magnified the decreasing effect of EMPs on inflammation-related factors. Conclusion: The present study reveals that EMPs are capable of alleviating lung inflammation and transferring miR-126 can magnify the anti-inflammatory effect of EMPs, which may provide a novel therapeutic alternative for COPD. Keywords: chronic obstructive pulmonary disease, endothelial microparticles, primary pulmonary microvascular endothelial cell, inflammation, microRNA-126 According to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2021 report, 1 chronic obstructive pulmonary disease (COPD) is a preventable and treatable respiratory disease usually caused by exposure to toxic particles or gases, and it is characterized by persistent respiratory symptoms and airflow limitation due to respiratory and/or alveolar abnormalities. COPD has become a public health problem all over the world, and it caused 2.6% of global disability-adjusted life years (DALYs) during 1990 to 2015. 2 The China Pulmonary Health (CPH) study demonstrated that the overall prevalence of spirometry-defined COPD in Chinese adult population was 8.6%. 3 Several mechanisms are involved in the development of COPD including inflammation, imbalance between proteolytic and anti-proteolytic activity, oxidative stress and apoptosis, and there exists interaction among different mechanisms. 4 Chronic inflammation of the airways plays a central role in the pathophysiology of COPD. 5,6 The risk factors of COPD patients are heterogeneous in the population. Existing studies show that the risk factors of COPD mainly include genetic factors, environmental factors (smoking, air pollution, occupational exposure, infection, etc.) and bad lifestyles (eating habits and daily exercise). 7 Cigarette smoke exposure is considered to be the primary risk factor for the decline of lung function and the incidence of COPD. 8–10 In addition, previous studies have also proved that cigarette smoke exposure participates in the occurrence and development of COPD by inducing airway inflammatory response, oxidative stress injury, lung structural cell aging and cell death. 11,12 Endothelial microparticles (EMPs) are extracellular vesicles (EVs) less than 1 μm in diameter released from the surface of endothelial cells when they are activated or apoptotic. EMPs have some antigenic properties of endothelial cells and are considered to play important biological roles in inflammation, vascular injury, endothelial dysfunction and thrombosis. 13 Recently, evidence has proved that EVs can be new types of intercellular communication media, which can carry nucleic acid, protein and other components to transport between cells and participate in the pathogenesis of chronic lung diseases. 14 As one of the most common transferring components of extracellular vesicle, microRNAs (miRNAs) are involved in the pathogenesis of a variety of inflammatory diseases. 15–17 miRNA is a small noncoding RNA, which plays an important role in post transcriptional gene regulation, and the regulation of gene expression by miRNA may occur in three stages of transcription/translation pr -Abstract Truncated-
immunology